Offer - Urjas Oil for just ₹ 1
New Triclazone 40 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Diabetes Type 2, Diabetes Type 2, Diabetes are some of its major therapeutic uses. The alternative uses of New Triclazone 40 Tablet have also been explained below.
The optimal dosage of New Triclazone 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with New Triclazone 40 Tablet include Constipation, Abdominal Pain, Indigestion. Some other side effects of New Triclazone 40 Tablet have been listed ahead. Usually, these side effects of New Triclazone 40 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
New Triclazone 40 Tablet's effect during pregnancy is Mild and Moderate while nursing. Further, the section on New Triclazone 40 Tablet related warnings talks about New Triclazone 40 Tablet's effects on the liver, heart and kidney.
New Triclazone 40 Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease, Diabetic Ketoacidosis as it can result in adverse effects. Some other conditions that can be affected by New Triclazone 40 Tablet are listed in the contraindications section below.
Drug interactions for New Triclazone 40 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that New Triclazone 40 Tablet is safe while driving, and is addiction.
New Triclazone 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of New Triclazone 40 Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Triclazone has mild side effects when taken during pregnany
Is the use of New Triclazone 40 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Triclazone. If you see any side effects, stop taking Triclazone immediately and talk to your doctor. Take Triclazone again, only after your doctor's advice.
What is the effect of New Triclazone 40 Tablet on the Kidneys?
Triclazone is completely safe for kidneys.
What is the effect of New Triclazone 40 Tablet on the Liver?
Using Triclazone does not have any harmful effects on the liver.
What is the effect of New Triclazone 40 Tablet on the Heart?
Triclazone is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take New Triclazone 40 Tablet unless your doctor advises you to do so -
Is this New Triclazone 40 Tablet habit forming or addictive?
New Triclazone 40 Tablet is not addictive in nature.
Interaction between Food and New Triclazone 40 Tablet
Information is not available on the interaction of any foods with New Triclazone 40 Tablet, due to a lack of research on this.
Interaction between Alcohol and New Triclazone 40 Tablet
Taking New Triclazone 40 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826